Cargando…

Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas

OBJECTIVE: Ovarian metasteses are often mistaken for primary adenocarcinoma. Studies conducted in recent years have focused on a search for an immunohistochemical marker to aid the differential diagnosis primary and metastatic ovarian carcinoma. Our study objective was to study the usefulness of Wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Şakirahmet Şen, Dilek, Gökmen Karasu, Ayşe Filiz, Özgün Geçer, Melin, Karadayı, Nimet, Ablan Yamuç, Elif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558354/
https://www.ncbi.nlm.nih.gov/pubmed/28913087
http://dx.doi.org/10.4274/tjod.22220
_version_ 1783257376015515648
author Şakirahmet Şen, Dilek
Gökmen Karasu, Ayşe Filiz
Özgün Geçer, Melin
Karadayı, Nimet
Ablan Yamuç, Elif
author_facet Şakirahmet Şen, Dilek
Gökmen Karasu, Ayşe Filiz
Özgün Geçer, Melin
Karadayı, Nimet
Ablan Yamuç, Elif
author_sort Şakirahmet Şen, Dilek
collection PubMed
description OBJECTIVE: Ovarian metasteses are often mistaken for primary adenocarcinoma. Studies conducted in recent years have focused on a search for an immunohistochemical marker to aid the differential diagnosis primary and metastatic ovarian carcinoma. Our study objective was to study the usefulness of Wilms tumor 1 (WT 1) antigen in this context. MATERIALS AND METHODS: The study was conducted at the pathology clinic of Lütfi Kırdar Training and Research Hospital. Deparaffinated blocks of 40 epithelial ovarian tumors, 40 colon adenocarcinomas, and 35 cases of omentum metastases were studied. Cytokeratin 7 (CK 7), cytokeratin 20 (CK 20), and WT 1 were applied to all specimens. RESULTS: All ovarian adenocarcinomas were stained with CK 7 (100%). Colorectal adenocarcinomas were stained positive with CK 20 in 87.5% of cases. Primary ovarian adenocarcinomas stained positive with WT 1 in 82.5% of the cases and none of the colorectal adenocarcinomas showed staining with WT 1 (0%). CONCLUSION: WT 1 can be used in conjuction with CK 7 in the differential diagnosis of ovarian carcinomas.
format Online
Article
Text
id pubmed-5558354
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-55583542017-09-14 Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas Şakirahmet Şen, Dilek Gökmen Karasu, Ayşe Filiz Özgün Geçer, Melin Karadayı, Nimet Ablan Yamuç, Elif Turk J Obstet Gynecol Clinical Investigation OBJECTIVE: Ovarian metasteses are often mistaken for primary adenocarcinoma. Studies conducted in recent years have focused on a search for an immunohistochemical marker to aid the differential diagnosis primary and metastatic ovarian carcinoma. Our study objective was to study the usefulness of Wilms tumor 1 (WT 1) antigen in this context. MATERIALS AND METHODS: The study was conducted at the pathology clinic of Lütfi Kırdar Training and Research Hospital. Deparaffinated blocks of 40 epithelial ovarian tumors, 40 colon adenocarcinomas, and 35 cases of omentum metastases were studied. Cytokeratin 7 (CK 7), cytokeratin 20 (CK 20), and WT 1 were applied to all specimens. RESULTS: All ovarian adenocarcinomas were stained with CK 7 (100%). Colorectal adenocarcinomas were stained positive with CK 20 in 87.5% of cases. Primary ovarian adenocarcinomas stained positive with WT 1 in 82.5% of the cases and none of the colorectal adenocarcinomas showed staining with WT 1 (0%). CONCLUSION: WT 1 can be used in conjuction with CK 7 in the differential diagnosis of ovarian carcinomas. Galenos Publishing 2016-03 2016-03-10 /pmc/articles/PMC5558354/ /pubmed/28913087 http://dx.doi.org/10.4274/tjod.22220 Text en © Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigation
Şakirahmet Şen, Dilek
Gökmen Karasu, Ayşe Filiz
Özgün Geçer, Melin
Karadayı, Nimet
Ablan Yamuç, Elif
Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
title Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
title_full Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
title_fullStr Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
title_full_unstemmed Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
title_short Utilization of Wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
title_sort utilization of wilms’ tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558354/
https://www.ncbi.nlm.nih.gov/pubmed/28913087
http://dx.doi.org/10.4274/tjod.22220
work_keys_str_mv AT sakirahmetsendilek utilizationofwilmstumor1antigeninapanelfordifferentialdiagnosisofovariancarcinomas
AT gokmenkarasuaysefiliz utilizationofwilmstumor1antigeninapanelfordifferentialdiagnosisofovariancarcinomas
AT ozgungecermelin utilizationofwilmstumor1antigeninapanelfordifferentialdiagnosisofovariancarcinomas
AT karadayınimet utilizationofwilmstumor1antigeninapanelfordifferentialdiagnosisofovariancarcinomas
AT ablanyamucelif utilizationofwilmstumor1antigeninapanelfordifferentialdiagnosisofovariancarcinomas